Cardinal Health (CAH) Competitors $164.80 +2.82 (+1.74%) Closing price 07/3/2025 03:41 PM EasternExtended Trading$164.80 0.00 (0.00%) As of 07/3/2025 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CAH vs. DXCM, HOLX, MMSI, AMN, COR, ELV, HAE, ITGR, MCK, and HSICShould you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include DexCom (DXCM), Hologic (HOLX), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Cencora (COR), Elevance Health (ELV), Haemonetics (HAE), Integer (ITGR), McKesson (MCK), and Henry Schein (HSIC). These companies are all part of the "medical" sector. Cardinal Health vs. Its Competitors DexCom Hologic Merit Medical Systems AMN Healthcare Services Cencora Elevance Health Haemonetics Integer McKesson Henry Schein Cardinal Health (NYSE:CAH) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership. Do analysts rate CAH or DXCM? Cardinal Health currently has a consensus price target of $157.43, suggesting a potential downside of 4.47%. DexCom has a consensus price target of $98.50, suggesting a potential upside of 19.06%. Given DexCom's stronger consensus rating and higher probable upside, analysts plainly believe DexCom is more favorable than Cardinal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardinal Health 0 Sell rating(s) 3 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.79DexCom 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 3 Strong Buy rating(s) 2.95 Do institutionals & insiders hold more shares of CAH or DXCM? 87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.1% of Cardinal Health shares are held by company insiders. Comparatively, 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is CAH or DXCM more profitable? DexCom has a net margin of 12.90% compared to Cardinal Health's net margin of 0.70%. DexCom's return on equity of 30.05% beat Cardinal Health's return on equity.Company Net Margins Return on Equity Return on Assets Cardinal Health0.70% -68.84% 4.21% DexCom 12.90%30.05%10.00% Which has more risk and volatility, CAH or DXCM? Cardinal Health has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500. Does the media prefer CAH or DXCM? In the previous week, DexCom had 5 more articles in the media than Cardinal Health. MarketBeat recorded 31 mentions for DexCom and 26 mentions for Cardinal Health. Cardinal Health's average media sentiment score of 1.29 beat DexCom's score of 1.12 indicating that Cardinal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardinal Health 20 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 24 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, CAH or DXCM? Cardinal Health has higher revenue and earnings than DexCom. Cardinal Health is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardinal Health$226.83B0.17$852M$6.4125.71DexCom$4.03B8.04$576.20M$1.3461.74 SummaryDexCom beats Cardinal Health on 13 of the 17 factors compared between the two stocks. Get Cardinal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CAH vs. The Competition Export to ExcelMetricCardinal HealthMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$39.37B$15.70B$5.56B$20.71BDividend Yield1.24%1.40%5.22%3.71%P/E Ratio25.7119.9027.6628.10Price / Sales0.172.18423.0038.31Price / Cash15.6617.3536.8922.53Price / Book-12.493.838.034.58Net Income$852M$430.42M$3.18B$985.54M7 Day Performance-1.43%1.64%2.93%2.79%1 Month Performance6.54%0.78%1.72%4.37%1 Year Performance71.86%21.84%34.39%15.08% Cardinal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CAHCardinal Health4.8219 of 5 stars$164.80+1.7%$157.43-4.5%+71.9%$39.37B$226.83B25.7148,900Positive NewsEx-DividendAnalyst RevisionDXCMDexCom4.8971 of 5 stars$87.34+1.2%$98.50+12.8%-27.2%$34.25B$4.03B65.187,600Positive NewsHOLXHologic4.8241 of 5 stars$65.25+0.4%$77.42+18.6%-12.6%$14.54B$4.03B27.537,063Positive NewsMMSIMerit Medical Systems4.3182 of 5 stars$93.66+0.2%$109.11+16.5%+9.4%$5.54B$1.36B45.917,400News CoveragePositive NewsAMNAMN Healthcare Services4.305 of 5 stars$20.82-0.3%$32.08+54.1%-54.8%$796.99M$2.98B-4.812,968News CoverageAnalyst RevisionCORCencora4.6706 of 5 stars$299.320.0%$306.33+2.3%+33.0%$58.01B$293.96B34.7242,000News CoveragePositive NewsAnalyst RevisionELVElevance Health4.9754 of 5 stars$388.78+1.9%$498.87+28.3%-34.2%$87.84B$183.12B15.17102,300HAEHaemonetics4.8718 of 5 stars$74.90+1.5%$96.80+29.2%-9.5%$3.60B$1.36B22.633,023Positive NewsITGRInteger3.6243 of 5 stars$123.23+0.5%$145.00+17.7%+4.1%$4.30B$1.75B58.4011,000MCKMcKesson4.3387 of 5 stars$732.36+0.9%$696.42-4.9%+22.4%$91.63B$359.05B28.3575,000Trending NewsAnalyst UpgradeAnalyst RevisionHSICHenry Schein3.0725 of 5 stars$73.10-0.2%$79.30+8.5%+14.9%$8.90B$12.67B22.8425,000News CoveragePositive News Related Companies and Tools Related Companies DexCom Competitors Hologic Competitors Merit Medical Systems Competitors AMN Healthcare Services Competitors Cencora Competitors Elevance Health Competitors Haemonetics Competitors Integer Competitors McKesson Competitors Henry Schein Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CAH) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 4th: 59% dividend from Bitcoin (No Crypto Needed)I've got something exciting for you this July 4th holiday... How about a 59.07% dividend from Bitcoin? Y...Investors Alley | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardinal Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardinal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.